about
Intravesical Bacillus Calmette-Guérin versus epirubicin for Ta and T1 bladder cancerDNA and the chromosome - varied targets for chemotherapyHuman papilloma virus and squamous cell carcinoma of the anusSmall-Molecule Procaspase-3 Activation Sensitizes Cancer to Treatment with Diverse ChemotherapeuticsMitomycin C and decarbamoyl mitomycin C induce p53-independent p21WAF1/CIP1 activationMitomycin C in the treatment of gastrointestinal tumours: recent data and perspectives.Prevention of posterior glottic stenosis by mitomycin C.Effect of topical mitomycin C on the healing of surgical and laser wounds: a hint on clinical application.Mitomycin C in combination with vinorelbine in anthracycline- and/or taxane-pretreated patients with metastatic breast cancer.Validation and use of microdialysis for determination of pharmacokinetic properties of the chemotherapeutic agent mitomycin C - an experimental studyThe SOS and RpoS Regulons Contribute to Bacterial Cell Robustness to Genotoxic Stress by Synergistically Regulating DNA Polymerase Pol II.Combined Chemotherapy with Mitomycin C, Folinic Acid, and 5-Fluorouracil (MiFoFU) as Salvage Treatment for Patients with Liver Metastases from Breast Cancer - a Retrospective AnalysisDecarbamoyl mitomycin C (DMC) activates p53-independent ataxia telangiectasia and rad3 related protein (ATR) chromatin eviction.A phase I dose escalation study of a pharmacobiologically based scheduling of capecitabine and mitomycin C in patients with gastrointestinal malignanciesModification of cellular DNA by synthetic aziridinomitosenes.Efficacy of holmium laser urethrotomy and intralesional injection of Santosh PGI tetra-inject (Triamcinolone, Mitomycin C, Hyaluronidase and N-acetyl cysteine) on the outcome of urethral strictures.Convergent synthesis of a steroidal antiestrogen-mitomycin C hybrid using "click" chemistry.Intravesical mitomycin C for superficial transitional cell carcinoma.Autoantigen-specific immunosuppression with tolerogenic peripheral blood cells prevents relapses in a mouse model of relapsing-remitting multiple sclerosis.Synthetic and biosynthetic studies on FR900482 and mitomycin C: an efficient and stereoselective hydroxymethylation of an advanced benzazocane intermediate.Impact of DNA damaging agents on genome-wide transcriptional profiles in two marine Synechococcus speciesCell-centric view of apoptosis and apoptotic cell death-inducing antitumoral strategiesSynthetic Studies Towards the Mitomycins: Construction of the Tetracyclic Core via a Reductive Aminocyclization Reaction.Combatting bacterial persister cells.Cell therapeutic approaches to immunosuppression after clinical kidney transplantation.Synthesis-enabled probing of mitosene structural space leads to improved IC₅₀ over mitomycin C.Riboflavin-targeted polymer conjugates for breast tumor delivery.Tackling non-muscle invasive bladder cancer in the clinic.Anticancer Properties and Pharmaceutical Applications of Plumbagin: A Review.Persistent DNA damage caused by low levels of mitomycin C induces irreversible cell senescence.First synthesis of an aziridinyl fused pyrrolo[1,2-a]benzimidazole and toxicity evaluation towards normal and breast cancer cell lines.Synthesis of model morpholine derivatives with biological activities by laccase-catalysed reactions.DNA-crosslinker cisplatin eradicates bacterial persister cells.Combatting bacterial infections by killing persister cells with mitomycin C.Development of a flexible strategy towards FR900482 and the mitomycinsSingle-step assembly of polymer-lipid hybrid nanoparticles for mitomycin C delivery.Mitomycins syntheses: a recent update.Comparative Error-Free and Error-Prone Translesion Synthesis of N(2)-2'-Deoxyguanosine Adducts Formed by Mitomycin C and Its Metabolite, 2,7-Diaminomitosene, in Human Cells.Effect of topical use of mitomycin C and 5-fluorouracil on the closure time of myringotomies created by radiofrequency unit.Mitomycin C-enhanced revision endoscopic dacryocystorhinostomy: a prospective randomized controlled trial.
P2860
Q24234614-F2AF5028-100C-441C-8B3A-55E06482F5D6Q24792540-6071AE3A-DB20-4ACC-8E67-4BFBB2D18AA9Q26820863-369BB3DC-FBA1-4527-9C11-720A1BA77002Q29027136-F630251D-3683-4A95-9EC7-67D2480BECC7Q30372329-51E43513-DEF8-42CD-922F-B8E1D4E8178EQ31156315-0BCB15E1-5E2B-4113-8AD9-8F7BD382CAABQ33222635-281847F1-2F39-4161-A01E-8F8B69735368Q33229745-51A7FF37-5671-4A58-9910-D8982BFA3A6BQ33403508-7AA70499-D8A3-49B4-9FE7-409D6B2DCDD3Q33681531-5D5C8E84-0526-4945-83FD-DDA934984AD3Q33880011-CF8D80ED-A3BE-429B-B066-918EE5D659F0Q34284297-E8FCED3D-DF75-45B5-A91F-A4316A331424Q34456932-937AAE48-0E3D-46E4-9C1C-2C341BB443BFQ34665196-8B82F974-3DAC-475A-857E-EF2D396BD643Q35833908-33827A8F-DEA6-4DA8-AFF5-93476E500D4DQ35917403-5D766637-EC73-4CBC-B420-AE969AAEC05AQ36458699-FAAAF0D0-612A-4976-981D-9AAAF1A2F926Q36573853-6C36F0A4-4108-4AAD-BC3E-EAFC3004250CQ36854682-1F037F1A-7240-4318-B490-A8C82FEDA828Q36935106-8DCA008E-4ABA-48EC-A8C9-742F456DA087Q37098686-8D8DC67B-389D-42AA-B924-0B68B9F02486Q37129849-3A07EC0E-0133-4011-B304-76D37E655C09Q37243502-10609148-E5B3-4CC0-ABF7-6987BF86F11AQ38564616-C4B9B8F7-7FDD-4EAD-9E23-A9CEBEEA8831Q38754342-D0D6C62B-9788-48C2-88C0-D1DF1DBF74A1Q38973558-5A86F8D9-49D0-4D56-A0B2-4DCF2C02B31EQ39169209-C53CA302-6D0C-42B9-8245-E56D3F69C1B6Q39209020-C552666F-5A34-44EC-98B5-DE934AD09F4CQ39209049-02254A07-374C-4497-827A-19807B47D6DBQ39300990-44123EFC-50EE-4695-B0CD-2516BE179ED9Q39496632-5D2253D1-F513-4268-818F-F70664875025Q39793710-CF39AE03-2515-4925-8864-CE1C2573FCDAQ40777976-F6F305F8-38C8-4D0F-B9DC-06196E9F129EQ41347787-81061CBE-E3B0-427F-805F-38397585793AQ42064681-0CCCAE38-66B3-4884-BFF0-C56922909963Q42117333-55FD4D44-6EEE-4991-91EA-8CA97607C3BCQ42154508-362AD7A8-08F0-4DDD-A573-76640B2C5FD4Q42779965-37ABC62A-47E4-4188-9880-09B3805DB794Q43253481-DBF909DA-E120-4FD3-90E0-833DA992E65CQ46760367-EEE9F009-F313-44A7-B5F6-DFFE2C15D297
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Mitomycin C: a clinical update.
@ast
Mitomycin C: a clinical update.
@en
Mitomycin C: a clinical update.
@nl
type
label
Mitomycin C: a clinical update.
@ast
Mitomycin C: a clinical update.
@en
Mitomycin C: a clinical update.
@nl
prefLabel
Mitomycin C: a clinical update.
@ast
Mitomycin C: a clinical update.
@en
Mitomycin C: a clinical update.
@nl
P356
P1476
Mitomycin C: a clinical update.
@en
P2093
Bradner WT
P356
10.1053/CTRV.2000.0202
P577
2001-02-01T00:00:00Z